When administered to healthy mouse skin, IL-23 triggered the development of psoriasis-like lesions, characterized by epidermal hyperplasia, inflammatory cell infiltration, and the upregulation of several pro-inflammatory cytokines [105,106]. The gene discussed is IL37; the disease is psoriasis.